Analysis of adverse reactions and cost-driving factors during the induction phase of pediatric acute lymphoblastic leukemia
Adverse reactions and complications markedly burden induction treatment. Optimizing protocols, improving monitoring, and implementing cost-control measures can enhance outcomes and reduce costs. Larger sample sizes and socioeconomic variables should be included in future research.
Authors
- Chenhong Jia
- Xiaohui Chen (ORCID: https://orcid.org/0000-0002-7302-8771)
- Zhonghao Xu
- Xiangyu Ding (ORCID: https://orcid.org/0000-0002-9868-4345)
Institutions
- Hospital of Hebei Province (CN)
- Hebei Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Frontiers in Pediatrics
- Published
- 2025-11-14
- DOI
- https://doi.org/10.3389/fped.2025.1702696
- Citations
- 1
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 1.88